2009
DOI: 10.1136/bjo.2008.154435
|View full text |Cite
|
Sign up to set email alerts
|

Accelerated corneal graft rejection in baby rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
21
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(23 citation statements)
references
References 24 publications
2
21
0
Order By: Relevance
“…Corneal transplantation in pre-sensitized hosts with surface inflammation, in emergency situations [11], in very young recipients [12,13] or in patients with allergic or atopic afflictions [14,15] shows a higher rate of immune reactions leading to graft failure. Compared to low-risk situations, these patients require systemic immunosuppressive therapy with cyclosporin A or mycofenolate mofetile [10,14] in addition to topical corticosteroids.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Corneal transplantation in pre-sensitized hosts with surface inflammation, in emergency situations [11], in very young recipients [12,13] or in patients with allergic or atopic afflictions [14,15] shows a higher rate of immune reactions leading to graft failure. Compared to low-risk situations, these patients require systemic immunosuppressive therapy with cyclosporin A or mycofenolate mofetile [10,14] in addition to topical corticosteroids.…”
Section: Introductionmentioning
confidence: 99%
“…Most recently, the beneficial effect of AZM was reported in a mouse model of corneal transplantation [31]. We studied the effects of topically applied AZM in a well-established rat keratoplasty model [12,18] with a particular emphasis on the adequate time frame for treatment. Our data also supports the use of AZM to prevent corneal graft rejection and we strongly suggest that short-term perioperative application is sufficient to abrogate graft failure.…”
Section: Introductionmentioning
confidence: 99%
“…The upregulation of galectin-9 may dampen inflammation in the corneal allografts by promoting Treg cell polarization 26 and impairing the functions of natural killer cells, 27 which are also involved in corneal allograft rejection. 28 Notably, in control corneas, galectin-9 is mainly expressed in the epithelium. It has been reported that although corneal epithelium express over 90% of the major histocompatibility complex (MHC) antigens, removal of corneal epithelium does not enhance corneal graft survival in humans and even appears to exacerbate corneal allograft rejection in mice, 29-31 suggesting the corneal epithelium suppresses inflammation and neovascularization in corneal allografts.…”
Section: Discussionmentioning
confidence: 99%
“…[16][17][18] More recently, it was also reported that corneal grafts in infant rats were rejected at an accelerated rate. 19 Center for Eye Disease and Development, Program in Vision Science, School of Optometry, University of California, Berkeley, California. This study is supported in part by research grants from National Institutes of Health, Department of Defense, and the University of California at Berkeley.…”
Section: Introductionmentioning
confidence: 99%